No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
Based in Hohhot, China, Jinyu Bio-technology Co., Ltd. is a Chinese firm specializing in the development, production, and commercialization of biological products for animal health. Established in 1992, the company provides crucial vaccines designed to combat diseases such as foot-and-mouth disease, highly pathogenic avian influenza, brucellosis, rabies, and swine fever. These vital immunizations are supplied for a broad spectrum of animals, including pigs, poultry, ruminants, and companion pets. The entity formally adopted its current name, Jinyu Bio-technology Co., Ltd., in December 2015, having previously operated as Inner Mongolia Jinyu Group Co., Ltd.
www.jinyu.com.cnNo one on the platform currently holds 600201.SS.
No tracked institution reports a position in 600201.SS as of their last filing.
No one on the platform has traded 600201.SS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 2.3% | 5.6% | 15.9% | — | — | — |
| Rev. Growth % | 11.2% | -2.5% | ||||
| Profit Margin % | 7.2% | 13.8% | 24.2% | |||
| Free Cash Flow Margin % | 13.9% | 11.6% | 15.7% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $1.7B | +21.0% | $0.22 | $0.20–$0.25 | — | 3 |
| 2027 | $1.8B | +11.0% | $0.28 | $0.20–$0.37 | — | 4 |
| 2028 | $2.6B | +40.5% | $0.35 | $0.31–$0.41 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 1 of the last 3 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-04 | $0.20 | $0.02 | -90.1% |
| 2025-04-24 | $0.07 | $0.07 | +0.0% |
| 2025-04-24 | $0.07 | $-0.05 | -171.4% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 600201.SSJinyu Bio-technology Co., Ltd. | $11.65 | -0.34% | $12.9B | — |
| 000990.SZChengzhi Shareholding Co., Ltd. | $6.42 | +1.10% | $10.9B | — |
| 300181.SZZhejiang Jolly Pharmaceutical Co.,LTD | $13.19 | +0.23% | $9.1B | — |
| 300294.SZChina Resources Boya Bio-pharmaceutical Group Co., Ltd. | $13.98 | +0.29% | $7.0B | — |
| 300841.SZChengdu Kanghua Biological Products Co., Ltd. |
| $49.37 |
| +0.80% |
| $6.4B |
| — |
| 301207.SZHualan Biological Bacterin Inc. | $18.14 | +1.34% | $10.8B | — |
| 600645.SSVcanbio Cell & Gene Engineering Corp., Ltd | $17.83 | +0.00% | $8.1B | — |
Source: Financial Modeling Prep · peers by sector/industry